Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis
卡铂-紫杉醇与卡铂-紫杉醇-曲妥珠单抗治疗HER2/Neu过表达的晚期（III-IV期）或复发性子宫浆液性癌的随机II期试验（NCT01367002）：更新的总生存期分析
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-0953
Fader, Amanda N; Roque, Dana M; Siegel, Eric; Buza, Natalia; Hui, Pei; Abdelghany, Osama; Chambers, Setsuko; Secord, Angeles Alvarez; Havrilesky, Laura; O'Malley, David M; Backes, Floor J; Nevadunsky, Nicole; Edraki, Babak; Pikaart, Dirk; Lowery, William; ElSahwi, Karim; Celano, Paul; Bellone, Stefania; Azodi, Masoud; Litkouhi, Babak; Ratner, Elena; Silasi, Dan-Arin; Schwartz, Peter E; Santin, Alessandro D
